SCO-267
SCO-267 is a full agonist of GPR40/FFAR1 with an EC50 of 12 nM, effectively stimulating insulin secretion and GLP-1 release in diabetic rats, improving glucose tolerance, and can be used for the treatment of type 2 diabetes.
Product Specifications
CAS Number
1656261-09-4
Product Name Alternative
SCO 267, SCO267, SCO-267
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.89% (May vary between batches)
Solubility
DMSO:80 mg/mL (130.13 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (5.37 mM)
Smiles
C (N (CC (C) (C) C) C=1N=C (C) C=CC1) (=O) C2=C (C=C (OC) C=C2) N3CCC (COC4=CC ([C@@H] (CC (O) =O) [C@@H]5CC5) =CC=N4) CC3
Molecular Formula
C36H46N4O5
Molecular Weight
614.77
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC421155 20 µg
GPR105 (P2RY14) (NM_001081455) Human Over-expression Lysate
Sign In for Pricing
View Details 
M00574-carrier-free 100 µg/Vial
Anti-CASR Antibody Picoband® (monoclonal, 11E9), Carrier-free
Sign In for Pricing
View Details